MAM
IDYA icon

Meeder Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Meeder Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-251
Closed -$8.36K – 989
2026
Q1 		$8.36K Buy
251
+123
+96% +$4.13K ﹤0.01% 736
2025
Q4 		$4.42K Buy
+128
New +$4.08K ﹤0.01% 808
2025
Q3 		– Sell
-136
Closed -$2.86K – 870
2025
Q2 		$2.86K Sell
136
-39
-22% -$748 ﹤0.01% 783
2025
Q1 		$2.87K Sell
175
-4
-2% -$85 ﹤0.01% 837
2024
Q4 		$4.6K Buy
179
+55
+44% +$1.56K ﹤0.01% 842
2024
Q3 		$3.93K Buy
124
+26
+27% +$986 ﹤0.01% 778
2024
Q2 		$3.44K Buy
+98
New +$3.88K ﹤0.01% 813

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Meeder Asset Management's IDYA Position: Q2 2026 in Review

Meeder Asset Management sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 251 shares — an estimated $8.36K sold.

Meeder Asset Management first reported a position in IDYA in Q2 2024 and held it in 7 quarters. The position peaked at $8.36K in Q1 2026. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Meeder Asset Management reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Meeder Asset Management sold 251 IDEAYA Biosciences shares in Q2 2026, an estimated $8.36K.
  • Meeder Asset Management first reported a position in IDEAYA Biosciences in Q2 2024 and held it in 7 quarters.
  • Meeder Asset Management's IDEAYA Biosciences position peaked at $8.36K in Q1 2026.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.